Search

Search Constraints

You searched for: Author/Creator Pollicita, M.

Search Results

1. A high HBsAg genetic complexity can influence HBV immunogenicity in the setting of acute infection. (15th February 2015)

2. A hyper-glycosylation of HBV surface major hydrophilic region correlates with immunosuppression-driven HBV reactivation and hampers HBsAg recognition in vitro. (15th February 2015)

3. A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy. (December 2015)

4. HBsAg mutations correlated with HCC in vivo affect HBsAg release and favor cell proliferation in vitro. (10th February 2016)

5. HBV-HDV co-infection constrains HBV genetic evolution in HBsAg. (10th February 2016)

6. Immunosuppression-driven HBV reactivation in patients with resolved HBV infection correlates with a relevant risk of death and with evolution towards active chronical infection. (10th February 2016)

7. Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor. (November 2016)

8. Snapshot on drug‐resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. Issue 6 (12th April 2013)

9. Snapshot on drug‐resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice1. Issue 6 (12th April 2013)

10. Vaccine-escape HBsAg mutants circulating among genotype D HBV-infected patients correlate with atypical serological profiles, high viremia and transaminases: Potential impact on vaccination strategies. (10th February 2016)